Clinical Trials Browser

OTHER × High Grade Neuroendocrine Neoplasms × Endocrine × Clear all

NCT04412629 2026-04-06

Cabozantinib in High Grade Neuroendocrine Neoplasms

Phase 2 Active not recruiting

High Grade Neuroendocrine Neoplasms